1. Home
  2. WST vs KB Comparison

WST vs KB Comparison

Compare WST & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • KB
  • Stock Information
  • Founded
  • WST 1923
  • KB 2008
  • Country
  • WST United States
  • KB South Korea
  • Employees
  • WST N/A
  • KB N/A
  • Industry
  • WST Medical/Dental Instruments
  • KB Commercial Banks
  • Sector
  • WST Health Care
  • KB Finance
  • Exchange
  • WST Nasdaq
  • KB Nasdaq
  • Market Cap
  • WST 18.9B
  • KB 28.6B
  • IPO Year
  • WST N/A
  • KB N/A
  • Fundamental
  • Price
  • WST $256.66
  • KB $85.65
  • Analyst Decision
  • WST Strong Buy
  • KB
  • Analyst Count
  • WST 8
  • KB 0
  • Target Price
  • WST $329.43
  • KB N/A
  • AVG Volume (30 Days)
  • WST 539.7K
  • KB 118.4K
  • Earning Date
  • WST 10-23-2025
  • KB 10-23-2025
  • Dividend Yield
  • WST 0.34%
  • KB 2.30%
  • EPS Growth
  • WST N/A
  • KB 37.07
  • EPS
  • WST 6.68
  • KB 10.86
  • Revenue
  • WST $2,960,200,000.00
  • KB $11,023,622,707.00
  • Revenue This Year
  • WST $6.28
  • KB $14.37
  • Revenue Next Year
  • WST $6.02
  • KB $2.09
  • P/E Ratio
  • WST $38.47
  • KB $7.66
  • Revenue Growth
  • WST 2.90
  • KB 10.10
  • 52 Week Low
  • WST $187.43
  • KB $46.38
  • 52 Week High
  • WST $352.33
  • KB $92.39
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.07
  • KB 62.46
  • Support Level
  • WST $254.35
  • KB $84.51
  • Resistance Level
  • WST $264.06
  • KB $86.50
  • Average True Range (ATR)
  • WST 5.88
  • KB 0.90
  • MACD
  • WST 0.41
  • KB 0.85
  • Stochastic Oscillator
  • WST 66.99
  • KB 91.61

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

Share on Social Networks: